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 Sepsis lacks pathognomonic clinical features and a de-
finitive biochemical or histological diagnostic test.1 As 
a result, since 1992, diagnosis of sepsis has been based 
on the presence of two or more of the criteria character-
ising the systemic inflammatory response syndrome 
(SIRS) (Table 1) arising from suspected or proven infec-
tion.2 
In response to data questioning this construct,3-7 new cri-
teria redefining sepsis, based on the Sequential Organ 
Failure Assessment (SOFA) score, have been proposed: 
Sepsis-38 (Table 1). The epidemiological and clinical 
implications of adopting these new criteria are currently 
unknown. We aimed to estimate the impact of adopting 
SOFA-based diagnostic criteria for sepsis on the diagno-
sis and apparent mortality of sepsis in Australian and 
New Zealand intensive care units. 
Methods 
Study design and population 
We conducted post-hoc analyses of prospectively col-
lected data from the point prevalence program (PPP) of 
the Australian and New Zealand Intensive Care Society 
Clinical Trials Group, which consisted of data from sin-
gle-day point prevalence studies conducted regularly in 
a large proportion of Australian and New Zealand ICUs. 
All patients present in participating ICUs at 10 am on 
seven PPP study days between 2009 and 2014 were in-
cluded. In this dataset, patients were contemporaneously 
diagnosed with sepsis if they had a presumed or proven 
infection and satisfied two or more criteria for SIRS. We 
assessed this cohort to calculate the proportion who 
would also satisfy the Sepsis-3 SOFA criteria. 
We also analysed the cohort of patients who were admit-
ted to the ICU within the 48 hours before data collection 
and whose principal reason for ICU admission was in-
fective pathology (see eBox 1, in online appendix at 
cicm.org.au/Resources/Publications/Journal). We used 
this cohort to calculate how many patients would satisfy 
the SOFA criteria even if they did not satisfy the SIRS 
criteria. 
We obtained ethics approval for data collection and use 
annually at each participating hospital.  
Data and statistical analysis 
We calculated SOFA scores for patients from worst rec-
orded values on each study day. We made no assump-
tions about pre-existing organ dysfunction and assumed 
a baseline SOFA score of 0 (see Methods and eTable 1 
in online appendix).9,10 When data were missing, we ex-
cluded the patients from the analysis and reduced the de-
nominator accordingly. We made no assumptions about 
missing data. 
ABSTRACT 
Objective: To estimate the impact of adopting the proposed new 
diagnostic criteria for sepsis, based on Sequential Organ Failure 
Assessment (SOFA) criteria, on the diagnosis and apparent mortality 
of sepsis in Australian and New Zealand intensive care units. 
Design, setting and participants: A two-stage, post hoc analysis of 
prospectively collected ICU research data from 3780 adult patients in 
77 Australian and New Zealand ICUs on 7 study days, between 2009 
and 2014. 
Main outcome measures: The proportion of patients who were 
diagnosed with sepsis using the criteria for systemic inflammatory 
response syndrome (SIRS) and who met the SOFA criteria for sepsis, 
and the proportion of patients who were admitted to the ICU with a 
diagnosis consistent with infection, who meet either, both or neither 
sets of criteria for sepsis; comparison of the demographic differences 
and in-hospital mortality between these groups. 
Results: Of 926 patients diagnosed with sepsis on a study day using 
SIRS criteria, 796/923 (86.2% [95% CI, 84.0%–88.5%]) satisfied the 
SOFA criteria. In-hospital mortality was similar in these groups, with 
death recorded for 216/872 patients (24.8% [95% CI, 21.9%–27.8%]) 
who met the SIRS criteria for sepsis, and for 200/747 patients (26.8% 
[95% CI, 23.6%–30.1%]) who met both the SIRS and SOFA criteria 
for sepsis. Of 122 patients meeting the SIRS criteria but not the SOFA 
criteria, 16 (13.1% [95% CI, 7.7%–19.1%]) died. Of 241 patients 
admitted with infective pathology and complete data, 142 (58.9% 
[95% CI, 52.4%–65.2%]) satisfied the SIRS criteria for sepsis and 210 
(87.1% [95% CI, 82.2%–91.1%]) satisfied the SOFA criteria. Of the 
241 patients, 99 (41.1%) were not classified as having sepsis on the 
study day by SIRS criteria and, of these, 80 (80.8%) met the SOFA 
criteria. 
Conclusions: Adopting the SOFA criteria will increase the apparent 
incidence of sepsis in patients admitted to the ICU with infective 
pathology without affecting the mortality rate. Prospective evaluation 
of the effect of adopting the new definition of sepsis is required. 
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 The proportion of patients diagnosed with sepsis using 
SIRS criteria and SOFA criteria were calculated along 
with their relative in-hospital mortality. We compared 
the demographic characteristics of patients determined 
to have sepsis, based on SOFA criteria, using t tests. As 
there is no gold standard for the diagnosis of sepsis, we 
did not calculate sensitivity or specificity for either set 
of diagnostic criteria. We quantified agreement between 
the criteria using Cohen’s kappa. Because the patient 
groups selected using the new and old criteria were not 
independent, we did not calculate P for the comparison 
of in-hospital mortality, but drew inferences from the 
95% confidence intervals (CIs).  
We show data as means and standard deviations (SDs), 
or frequencies and percentages with 95% CIs, as appro-
priate. CIs of proportions and Cohen’s kappa were cal-
culated using Prism 6 (GraphPad), and t tests were per-
formed in SPSS Statistics, version 21.0 (IBM). We 
defined statistical significance as P < 0.05. 
Results 
926/3754 patients (24.7%) were diagnosed with sepsis 
on study day using SIRS criteria. 796/923 also satisfied 
the SOFA criteria (86.2% [95% CI, 84.0%–88.5%]) 
(Figure 1). Patients meeting the sepsis diagnostic criteria 
for both the SIRS and SOFA definitions were signifi-
cantly older than patients meeting SIRS criteria alone 
(SOFA score < 2) (Table 2) (mean age, 59.8 years [SD, 
17.0 years] v mean age, 53.0 years [SD, 19.6 years], re-
spectively; P < 0.003). Patients meeting both sets of 
sepsis diagnostic criteria also had higher mean Acute 
Physiology and Chronic Health Evaluation (APACHE) 
II scores for severity of disease (21.6 [SD, 7.5] v 17.8 
[SD, 7.5], respectively; P < 0.001), than patients meet-
ing SIRS criteria alone. In-hospital mortality was similar 
in patients identified as having sepsis by SIRS criteria 
alone and in those meeting both SIRS and SOFA criteria: 
216/872 (24.8% [95% CI, 21.9%–27.8%]) v 200/747 
(26.8% [95% CI, 23.6%–30.1%]) respectively. In com-
parison, only 16/122 patients (13.1% [95% CI, 7.7%–
19.1%]) meeting the SIRS but not the SOFA criteria 
died. 
A total of 1591 patients were admitted to the ICU in the 
48 hours before PPP data collection. Of these, 244 
(15.3%) had an admission diagnosis indicating infective 
pathology, of which 142/241 were determined to have 
sepsis on the study day, based on the SIRS criteria 
(58.9% [95% CI, 52.4%–65.2%]) (Figure 2). In compar-
ison, 210/241 had sepsis as defined by the Sepsis-3 
SOFA criteria (87.1% [95% CI, 82.2%–91.1%]). Pa-
tients with a SOFA score  2 were older (mean age, 62.9 
years [SD, 16.6 year] v 56.4 years [SD, 21.7]; P = 0.168) 
with significantly higher disease severity (mean 
APACHE II score, 19.7 [SD, 7.1] v 13.2 [SD, 6.6]; 
P < 0.001) than those with a SOFA score < 2 (Table 3).  
In-hospital mortality was equivalent in patients classi-
fied as having sepsis by the SIRS or SOFA criteria 
(28/135; 20.7% [95% CI, 14.2%–28.6%] v 40/198; 
20.2% [95% CI, 14.8%–26.5%]). Of the 99/241 patients 
(41.1%) not classified as having sepsis on a study day 
by SIRS criteria, 80/99 patients (80.8%) had a SOFA 
score  2 on the study day. We found poor agreement 
between the diagnostic criteria ( = 0.12 [95% CI, 0.02–
0.22]). 
Patient characteristics, by study day, are shown in eTable 
2 in the online appendix. 
 
Table 1. Definitions of sepsis 
SIRS criteria for sepsis (1992) 
Suspected infection and at least two of: 
 core temperature  
 > 38C or  
 < 36C 
 heart rate > 90 beats per minute 
 respiratory rate  
 > 20 breaths per minute or  
 PaCO2 < 32 mmHg or  
 mechanical ventilation for an acute process 
 white blood cell count  
 > 12  109/L or  
 < 4  109/L or  
 > 10% immature neutrophils. 
SOFA criteria for sepsis (2016) 
Suspected infection and acute change in SOFA score* of  2 
points consequent to infection (see eTable 1 in supplementary 
appendix online). 
SIRS = systemic inflammatory response syndrome. SOFA = sequential 
organ failure assessment. * Baseline SOFA score was assumed to be 0 in 
patients not known to have pre-existing organ dysfunction.  
Table 2. Characteristics of patients with sepsis on study 
day, by SOFA score 
 SOFA score 
Characteristic  2 (n = 796) < 2 (n = 127) 
Mean age, years (SD) 59.8 (17.0) 53.0 (19.6) 
Male, n (%)* 508 (63.8%) 82 (63.1%) 
Mean APACHE II score (SD) 21.6 (7.5) 17.8 (7.5) 
Hospital mortality at Day 28, n (%)* 200 (26.8%) 16 (13.1%) 
SOFA = sequential organ failure assessment. APACHE = Acute Physiol-
ogy and Chronic Health Evaluation. * Proportion of cases with recorded 
outcome. 
 
 Discussion 
Our data suggest that adopting the Sepsis-3 diagnostic 
criteria will increase the number of ICU patients diag-
nosed with sepsis. Of patients admitted to the ICU with 
an admission diagnosis consistent with infection, sub-
stantially more patients will satisfy the new SOFA crite-
ria than the existing SIRS criteria. The in-hospital 
mortality rate of patients diagnosed with sepsis in the 
ICU will be unaffected, whether the SIRS or SOFA cri-
teria are used. 
Implications of findings 
The aim of the new SOFA-based criteria is to provide a 
pragmatic tool capable of distinguishing individuals 
with infection at high risk of adverse outcomes from 
those with self-limiting, ‘uncomplicated’ infections, 
which the SIRS criteria is not capable of.11,12 Our data 
show that although the reported mortality rate from sep-
sis will be unaffected, patients with infective pathology 
at lower risk of in-patient death who would previously 
have been diagnosed with sepsis using the SIRS criteria 
would be excluded from the diagnosis of sepsis using the 
SOFA criteria. This is in accordance with prior studies 
showing that the SOFA score has a high predictive value 
for mortality in ICU cohorts.13,14 
A recent, large, observational study by Kaukonen and 
colleagues reported that about 10% of ICU patients with 
severe sepsis may not be diagnosed with sepsis (and thus 
“missed”) by the established SIRS criteria.7 The in-
creased proportion of patients with infective pathology 
diagnosed with sepsis using SOFA criteria, compared 
with SIRS criteria, along with the low in-hospital mor-
tality rate in patients with a SOFA score  2, suggests 
that these patients are captured by the Sepsis-3 defini-
tion. It is currently unknown whether this improved sen-
sitivity may be at the cost of reduced specificity.  
Figure 1. Proportion of ICU patients with sepsis on study 
day with SOFA score  2 or < 2* 
 
ICU = intensive care unit. SOFA = Sequential Organ Failure Assessment. 
IHM = in-hospital mortality, censored at 28 days. *  Patients diagnosed with 
sepsis on study day according to the presence of an organism grown in 
blood or other sterile site, or an abscess, or volume of infected tissue; and 
by meeting  two criteria for systemic inflammatory response syndrome;2 
scores calculated from five domains (respiratory, coagulation, liver, cardio-
vascular renal).  
Figure 2. Proportion of ICU patients with admission 
diagnosis consistent with sepsis or infection ( 48 
hours since admission) meeting SIRS and SOFA 
diagnostic criteria* 
 
ICU = intensive care unit. SIRS = systemic inflammatory response syn-
drome. SOFA = Sequential Organ Failure Assessment. IHM  = in-hospital 
mortality, censored at 28 days. APACHE = Acute Physiology and Chronic 
Health Evaluation. * Patients in the Australian and New Zealand Intensive 
Care Society point prevalence program registry admitted within 48 hours 
before data collection, with an APACHE II primary diagnosis consistent 
with sepsis or infection (see eBox 1 in supplementary appendix online), 
were divided into patients meeting  two or < two SIRS criteria.17 Within 
each group, the proportions of patients meeting the new criteria for sepsis 
(SOFA score  2) and not meeting them (SOFA score < 2) were calcu-
lated. Outcome was calculated as a proportion of individuals with an in-
fective admission diagnosis overall and patients meeting the current 
definition of sepsis ( two SIRS criteria) or or not meeting it (< two SIRS 
criteria). SOFA scores were calculated from five domains (respiratory, co-
agulation, liver, cardiovascular and renal) excluding neurological. 
 The low level of agreement (kappa) observed between 
the SIRS and SOFA criteria suggests that the Sepsis-3 
definition may identify a different patient cohort to the 
existing criteria. Our data show that this population will 
be older and sicker (with higher APACHE II scores). The 
clinical repercussions of designating only patients with 
infection and established organ failure as having sepsis 
remain unknown. The mortality of the patients not iden-
tified as having sepsis using SOFA criteria may increase 
if the absence of a diagnosis of sepsis leads to delayed 
or less intense monitoring and treatment. Further, the 
implementation of early warning detection systems 
based on the SIRS criteria, with treatment bundles, has 
been shown to lead to an enhanced process of care for 
patients with sepsis in New South Wales. These im-
proved processes were associated with improvements in 
outcome, including reduced mortality.15 It is unclear 
whether integration of the new SOFA-based diagnostic 
criteria into these algorithms will lead to comparable 
performance, or whether they will be useful for the early 
detection of clinical deterioration from non-infective 
conditions.16 
Strengths and weaknesses 
The PPP data represent bi-national data from self-se-
lected ICUs participating on a voluntary basis. The data 
are collected prospectively by trained research nurses 
and coordinators, many of whom have collected data for 
this program for many years; this suggests that the data 
are of high quality and the study is of high integrity. 
Post-hoc analysis inevitably restricts interpretation of 
the data. The proportion of patients meeting the SOFA-
based definition was not collected as a primary data 
point. Hence, the proportion of patients with SIRS-neg-
ative, SOFA-positive sepsis had to be inferred from pa-
tients admitted within 48 hours of a study day, with an 
admission diagnosis consistent with sepsis or infection. 
Additionally, as the SOFA score before a study day was 
not collected, differentiating between patients with an 
acute increase in SOFA score of  2 (meeting the new 
definition of sepsis) and those with a chronically ele-
vated SOFA score of  2 (not meeting the definition) was 
not possible. Further, the SOFA scores in the neurologi-
cal domain were not recorded. Their inclusion could 
only have increased the reported number of patients di-
agnosed with sepsis using the SOFA criteria. Mortality 
status was not known for 5% of patients.  
Our estimated mortality rate for patients who did not 
meet the new criteria for sepsis may be an underesti-
mate. These patients could have received additional 
monitoring and treatment which would not have oc-
curred without the diagnosis of sepsis. The true outcome 
of individuals who meet the SIRS but not the SOFA cri-
teria can only be determined prospectively.  
Conclusion 
Using SOFA-based sepsis diagnostic criteria defines an 
older patient population with higher disease severity. 
Retrospectively applying SOFA diagnostic criteria to 
Australian and New Zealand ICUs increased the number 
of ICU-treated patients diagnosed with sepsis without 
altering the apparent in-hospital mortality rate.  
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